|
CN104434855A
|
|
Memantine hydrochloride tablet and preparation method thereof
|
|
CN104434840A
|
|
Repaglinide tablet and preparation method thereof
|
|
CN104490843A
|
|
Prescription and preparation process of esomeprazole magnesium enteric capsule
|
|
CN104434854A
|
|
Minodronic acid tablet and preparation process thereof
|
|
CN104447699A
|
|
Preparation method of esomeprazole magnesium trihydrate
|
|
CN104398485A
|
|
Olmesartan medoxomil tablet and preparation method thereof
|
|
CN104529791A
|
|
Preparation method of memantine hydrochloride
|
|
CN104497048A
|
|
Preparation method of minodronic acid
|
|
CN103550180A
|
|
Dasatinib tablet and preparation process thereof
|
|
CN103554099A
|
|
Preparation method of Dasatinib
|
|
CN103570686A
|
|
Method for synthesizing and refining esomeprazole sodium
|
|
CN103505424A
|
|
Preparation method for bortezomib for injection
|
|
CN103497233A
|
|
Preparation method for bortezomib
|
|
CN103494781A
|
|
Montelukast sodium chewing tablet prescription and preparation process thereof
|
|
CN103006585A
|
|
Preparation of injection esomeprazole sodium
|
|
CN103006609A
|
|
Anastrozole tablet composition and preparation method thereof
|
|
CN103012144A
|
|
Preparation method of flurbiprofen axetil
|
|
CN103006584A
|
|
Preparation method of pemetrexed disodium for injection
|
|
CN102988320A
|
|
Capecitabine dispersible tablet and preparation method thereof
|
|
CN102988285A
|
|
Docetaxel injection composition and preparation method thereof
|
